UBS Group’s Turmeric Acquisition Corp. Unit TMPMU Stock Holding History

UBS Group’s Portfolio TMPMU Stock Details TMPMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,831	Closed	-$18K	–	11951
2022 Q3	$18K	Sell	1,831 -673	-27%	-$6.72K	﹤0.01%	7574
2022 Q2	$25K	Buy	2,504 +1,205	+93%	+$12K	﹤0.01%	6634
2022 Q1	$13K	Buy	1,299 +300	+30%	+$2.98K	﹤0.01%	8128
2021 Q4	$10K	Sell	999 -100	-9%	-$1K	﹤0.01%	8856
2021 Q3	$11K	Sell	1,099 -200	-15%	-$2K	﹤0.01%	7950
2021 Q2	$13K	Buy	1,299 +112	+9%	+$1.13K	﹤0.01%	7831
2021 Q1	$12K	Buy	1,187 +1,149	+3,024%	+$12.2K	﹤0.01%	7825
2020 Q4	$0	Buy	+38	New	+$385	﹤0.01%	8957

UBS Group's TMPMU Position: Q4 2022 in Review

UBS Group sold out of Turmeric Acquisition Corp. Unit (TMPMU) in Q4 2022, closing a stake of 1,831 shares — an estimated $18K sold.

UBS Group first reported a position in TMPMU in Q4 2020 and held it in 8 quarters. The position peaked at $25K in Q2 2022. 0 funds tracked by Wall St. Rank hold TMPMU as of Q4 2022.

UBS Group reported no remaining Turmeric Acquisition Corp. Unit position as of Q4 2022 after selling out during the quarter.
UBS Group sold 1,831 Turmeric Acquisition Corp. Unit shares in Q4 2022, an estimated $18K.
UBS Group first reported a position in Turmeric Acquisition Corp. Unit in Q4 2020 and held it in 8 quarters.
UBS Group's Turmeric Acquisition Corp. Unit position peaked at $25K in Q2 2022.
0 funds tracked by Wall St. Rank held Turmeric Acquisition Corp. Unit as of Q4 2022.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.